Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG015404-04
Application #
6169131
Study Section
Special Emphasis Panel (SRC (05))
Program Officer
Bellino, Francis
Project Start
1997-09-30
Project End
2003-08-31
Budget Start
2000-09-30
Budget End
2003-08-31
Support Year
4
Fiscal Year
2000
Total Cost
$249,218
Indirect Cost
Name
University of California Davis
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
Davis
State
CA
Country
United States
Zip Code
95618
Rea, Miguel A; Zhou, Lei; Qin, Qin et al. (2006) Spontaneous immortalization of human epidermal cells with naturally elevated telomerase. J Invest Dermatol 126:2507-15
Gandour-Edwards, R; Mack, P C; Devere-White, R W et al. (2004) Abnormalities of apoptotic and cell cycle regulatory proteins in distinct histopathologic components of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 7:321-6
Martel, Cynthia L; Gumerlock, Paul H; Meyers, Frederick J et al. (2003) Current strategies in the management of hormone refractory prostate cancer. Cancer Treat Rev 29:171-87
Shi, Xu-Bao; Nesslinger, Nancy J; Deitch, Arline D et al. (2002) Complex functions of mutant p53 alleles from human prostate cancer. Prostate 51:59-72
Shi, X B; Gumerlock, P H; Muenzer, J T et al. (2001) BCL2 antisense transcripts decrease intracellular Bcl2 expression and sensitize LNCaP prostate cancer cells to apoptosis-inducing agents. Cancer Biother Radiopharm 16:421-9
Lara Jr, P N; Kung, H J; Gumerlock, P H et al. (1999) Molecular biology of prostate carcinogenesis. Crit Rev Oncol Hematol 32:197-208
deVere White, R W; Deitch, A D; Gumerlock, P H et al. (1999) Use of a yeast assay to detect functional alterations in p53 in prostate cancer: review and future directions. Prostate 41:134-42
Gumbiner, L M; Gumerlock, P H; Mack, P C et al. (1999) Overexpression of cyclin D1 is rare in human prostate carcinoma. Prostate 38:40-5